Digital Health China

China Femtech Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

China Femtech Market Industry Trends and Forecast to 2034: Segmented by (Type, Product, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

China · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $2.92 Bn Placeholder estimate
Estimate 2025 $3.37 Bn 9.3% of the global market
Projected 2034 $12.23 Bn 263% Adds $8.86 Bn over 9 forecast years
CAGR 2025–2034 15.4% Faster than 39% of 100 Digital Health markets here
Key players 6 Companies profiled
  • China is 9.26% of the global market.
  • In APAC, the largest is China (this report) at $3.37 Bn.
  • Fastest growing: India at 17% a year.
  • China ranks 1st of 10 by size in APAC.

Market size projection

China

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$8.86 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Femtech Market market size by year, China
YearMarket sizeChange that yearSince 2025
2024 (estimate) $2.92 Bn — —
2025 (base) $3.37 Bn +$449.5 Mn —
2026 (forecast) $3.89 Bn +$518.7 Mn +15.4%
2027 (forecast) $4.49 Bn +$598.6 Mn +33.2%
2028 (forecast) $5.18 Bn +$690.8 Mn +53.7%
2029 (forecast) $5.97 Bn +$797.2 Mn +77.3%
2030 (forecast) $6.89 Bn +$920.0 Mn +104.7%
2031 (forecast) $7.96 Bn +$1.06 Bn +136.2%
2032 (forecast) $9.18 Bn +$1.23 Bn +172.5%
2033 (forecast) $10.59 Bn +$1.41 Bn +214.5%
2034 (forecast) $12.23 Bn +$1.63 Bn +263%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

China Femtech Market Analysis at a glance
Market size, 2025$3.37 Bn placeholder estimate
Forecast, 2034$12.23 Bn placeholder estimate
Growth (CAGR), 2025–203415.4% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsType, product and end user (see all)
Key playersFlo Health, Clue (BioWink), Maven Clinic, Elvie (Chiaro), Natural Cycles and 1 more (see all)
Regulator in ChinaNMPASource: National Medical Products Administration. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The China Femtech Market Analysis Executive Summary

Femtech covers apps, devices and services built for women's health, from period tracking to fertility, pregnancy, menopause and pelvic health.

Key segments of the femtech market include type (Period and Fertility Tracking, Pregnancy and Nursing Care and Pelvic Health) and product (Apps, Wearables and Connected Devices).

Bar chart: China Femtech market size, 2024–2034, placeholder estimates. $2.92 Bn in 2024, $3.37 Bn in 2025 and $12.23 Bn in 2034, 15.4% CAGR.
China Femtech market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

China Femtech Market Dynamics

Market Growth Drivers

Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the femtech market. New products designed around women's biology and digital care are improving access.

Opportunity

Femtech, personalised care and new treatments for under-served conditions open strong growth for the femtech market, especially as employers and payers add women's health benefits.

Market Restraints

Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the femtech market.

Competitive Landscape for Femtech Market in China

The femtech market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Femtech Market in China

Femtech in China: rules and payment

Medical software is regulated as a medical device by the National Medical Products Administration (NMPA).⁠[1] Basic medical insurance covers most people; the National Healthcare Security Administration (NHSA) runs it and sets the National Reimbursement Drug List.⁠[2]

Policy changes and Reimbursement scenario

Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the femtech market. Government digital health programs in China are speeding up adoption.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Femtech right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Femtech in context

China compared

  • Health spending per person: 763 US$ per person (2023). World: 1,317 US$ per person (2023). 5th highest of the 15 countries we cover in APAC.[1]
  • Doctors: 3.11 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 3rd highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 14.9% of people (2025). World: 10.4% of people (2025). 6th highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 17 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Femtech market in China?
Placeholder estimate: about $3.37 Bn in 2025, rising to about $12.23 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Femtech market in China growing?
Placeholder estimate: about 15.4% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Femtech market report cover?
The report splits the market by type (Period and Fertility Tracking, Pregnancy and Nursing Care, Pelvic Health, Menopause Care and more), product (Apps, Wearables, Connected Devices, Services) and end user (Healthcare Providers, Patients, Payers, Pharmaceutical Companies).
Who are the key players in the Femtech market?
Key players include Flo Health, Clue (BioWink), Maven Clinic, Elvie (Chiaro), Natural Cycles and Oura.
What is driving the Femtech market?
Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the femtech market. New products designed around women's biology and digital care are improving access.
Who regulates Femtech in China?
Medical software is regulated as a medical device by the National Medical Products Administration (NMPA). Source: National Medical Products Administration. Checked 14 Nov 2026.
How is healthcare paid for in China?
Basic medical insurance covers most people; the National Healthcare Security Administration (NHSA) runs it and sets the National Reimbursement Drug List. Source: National Healthcare Security Administration. Checked 14 Nov 2026.
How much research is published on Femtech?
PubMed lists 68 papers on Femtech added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Digital Health reports in China

See all

Related on women's health and digital health

See the topic